Both in Biotechnology
Silexion Therapeutics vs Creative Medical Technology Holdings
Over the past year SLXN returned −99.6% and CELZ returned −82.0%; their daily moves had a correlation of 0.04.
SLXN −99.6% CELZ −82.0%Growth of $1, one year, split-adjusted
| Metric | SLXN | CELZ |
|---|---|---|
| Price | $0.1423 | $0.6784 |
| Market cap | $2.1M | $5.2M |
| Today | −7.11% | −5.78% |
| 1 month | −48.7% | −27.4% |
| 6 months | −97.7% | −69.8% |
| Year to date | −99.3% | −65.4% |
| 1 year | −99.6% | −87.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,716.9× |
| Net cash | — | $8.7M |
| Dividend yield | — | — |
| Volatility (60d) | 240.7% | 145.7% |
| Short % of float | 3.5% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).